Literature DB >> 23927533

Complement activation and mortality during an acute episode of thrombotic thrombocytopenic purpura.

T C Wu1, S Yang, S Haven, V M Holers, A S Lundberg, H Wu, S R Cataland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23927533     DOI： 10.1111/jth.12369

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  16 in total

1.  von Willebrand factor is a cofactor in complement regulation.

Authors:  Shuju Feng; Xiaowen Liang; Michael H Kroll; Dominic W Chung; Vahid Afshar-Kharghan
Journal:  Blood       Date:  2014-11-13       Impact factor: 22.113

Review 2.  ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.

Authors:  X Long Zheng
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739

3.  Von Willebrand factor regulates complement on endothelial cells.

Authors:  Damien G Noone; Magdalena Riedl; Fred G Pluthero; Mackenzie L Bowman; M Kathryn Liszewski; Lily Lu; Yi Quan; Steve Balgobin; Reinhard Schneppenheim; Sonja Schneppenheim; Ulrich Budde; Paula James; John P Atkinson; Nades Palaniyar; Walter H A Kahr; Christoph Licht
Journal:  Kidney Int       Date:  2016-05-25       Impact factor: 10.612

Review 4.  An international consensus approach to the management of atypical hemolytic uremic syndrome in children.

Authors:  Chantal Loirat; Fadi Fakhouri; Gema Ariceta; Nesrin Besbas; Martin Bitzan; Anna Bjerre; Rosanna Coppo; Francesco Emma; Sally Johnson; Diana Karpman; Daniel Landau; Craig B Langman; Anne-Laure Lapeyraque; Christoph Licht; Carla Nester; Carmine Pecoraro; Magdalena Riedl; Nicole C A J van de Kar; Johan Van de Walle; Marina Vivarelli; Véronique Frémeaux-Bacchi
Journal:  Pediatr Nephrol       Date:  2015-04-11       Impact factor: 3.714

Review 5.  The role of von Willebrand factor in thrombotic microangiopathy.

Authors:  Damien G Noone; Magdalena Riedl; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2017-07-26       Impact factor: 3.714

6.  Human neutrophil peptides and complement factor Bb in pathogenesis of acquired thrombotic thrombocytopenic purpura.

Authors:  Wenjing Cao; Huy P Pham; Lance A Williams; Jenny McDaniel; Rance C Siniard; Robin G Lorenz; Marisa B Marques; X Long Zheng
Journal:  Haematologica       Date:  2016-08-04       Impact factor: 9.941

7.  Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS13: a potential link of inflammation to TTP.

Authors:  Vikram G Pillai; Jialing Bao; Catherine B Zander; Jenny K McDaniel; Palaniappan S Chetty; Steven H Seeholzer; Khalil Bdeir; Douglas B Cines; X Long Zheng
Journal:  Blood       Date:  2016-05-13       Impact factor: 22.113

8.  Plasma levels of S100A8/A9, histone/DNA complexes, and cell-free DNA predict adverse outcomes of immune thrombotic thrombocytopenic purpura.

Authors:  Jingrui Sui; Ruinan Lu; Konstantine Halkidis; Nicole K Kocher; Wenjing Cao; Marisa B Marques; X Long Zheng
Journal:  J Thromb Haemost       Date:  2021-01-03       Impact factor: 5.824

9.  Factors influencing treatment of atypical hemolytic uremic syndrome.

Authors:  Carla M Nester; Richard J H Smith
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-18       Impact factor: 10.614

Review 10.  The interaction between the complement system and hemostatic factors.

Authors:  Selin Oncul; Vahid Afshar-Kharghan
Journal:  Curr Opin Hematol       Date:  2020-09       Impact factor: 3.218
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.